Zymeworks Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ZYME Nasdaq 2836 www.zymeworks.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zymeworks Inc.

JAZZ Rises on Updated OS Results From Gastric Cancer Study - Sep 1st, 2026 10:02 am
Zymeworks (ZYME), What Is Behind The Renewed Attention? - Aug 28th, 2026 1:05 pm
Is Zymeworks (ZYME) Stock Fully Priced After Its 301% Run? - Aug 28th, 2026 3:07 am
SJM, ZYME Stocks Hit 52-Week High – What’s Driving The Surge Today? - Aug 26th, 2026 11:59 am
JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer - Aug 26th, 2026 10:29 am
Jazz Pharmaceuticals Launches Ziihera After FDA Nod in HER2-Positive GEA - Aug 25th, 2026 6:02 pm
New Jazz cancer drug approval could drive blockbuster sales - Aug 25th, 2026 11:21 am
JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy - Aug 25th, 2026 10:26 am
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma - Aug 25th, 2026 8:23 am
Zymeworks Shares Rise Ahead of Key FDA Decision on Zanidatamab - Aug 24th, 2026 4:48 am
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - Aug 11th, 2026 7:30 am
Zymeworks Announces Participation in Upcoming Investor Conferences - Aug 11th, 2026 4:00 am
Zymeworks Inc. (ZYME) Reports Q2 Loss, Beats Revenue Estimates - Aug 6th, 2026 5:10 pm
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 2:05 pm
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 16th, 2026 4:00 am
Truist Remains Bullish on Zymeworks (ZYME) – Here’s Why - Jul 15th, 2026 2:33 am
Zymeworks (ZYME) Stock Looks Fully Valued Despite Its 205% Three Year Run - Jul 1st, 2026 4:10 am
Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead? - Jun 30th, 2026 7:21 am
Theravance Stock Down 3% After Zymeworks Announces Buyout - Jun 30th, 2026 6:54 am